Microneedle-Based Transdermal Drug Delivery: A Promising Approach for Enhanced Drug Permeation and Therapeutic Efficacy
Year: 2026
Type: article
Abstract: The stratum corneum restricted passive delivery of many hydrophilic drugs and biologics, even when these agents were suitable for treatment at or beneath the skin. This narrative review examined how microneedles altered that barrier, what experimental and clinical studies established about performance, and which translational requirements were relevant to Peshawar, Khyber Pakhtunkhwa, Pakistan. It drew on literature published from 2021 through 2026 and organized findings by device architecture, stage of evidence, and intended use. Solid, coated, dissolving, hollow, and hydrogel-forming arrays offered distinct ways to create a pathway, deposit a drug, or sustain its release. Their performance depended on how much active ingredient reached the intended tissue and, on the timing, and variability of delivery. Peshawar-affiliated studies examined glimepiride and ibuprofen formulations and reported systemic exposure in healthy volunteers. International trials illustrated different clinical outcomes. A measles–rubella patch induced immune responses in an early Gambian trial, whereas a transdermal abaloparatide system failed to meet a prespecified noninferiority criterion for lumbar spine bone mineral density. These findings supported product-specific evaluation. For Peshawar, the review identified priorities in delivered-dose testing, stability under intended storage conditions, usability, and comparison with established care. The evidence supported further development of selected formulations and provided a basis for evaluating them in the local health system.
DOI: 10.67785/pjpp.10.445
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Keywords: microneedles, transdermal drug delivery, stratum corneum barrier, drug permeation, hydrogel-forming microneedles, dissolving microneedles, hollow microneedles, coated microneedles, glimepiride, ibuprofen, abaloparatide, bone mineral density, systemic exposure, translational research, Peshawar
Open Access status: hybrid
OpenAlex ID: W7225984642
